Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Drug Monitoring

8 articoli — 2009-2023

RI Appunti di Neuropsichiatria
Il risperidone

Bazzoni M, Adragna C, Carucci S.

2023/2 — pag. 111-115 — DOI

Risperidone is one of the most common pharmacological treatments for psychiatric disorders in children and adolescents. Although over the last decades its efficacy and its relatively safe and easy use have been confirmed for several psychiatric disor...

RI Appunti di Neuropsichiatria
Metilfenidato e ADHD

Carucci S

2021/5 — pag. 325-328 — DOI

Methylphenidate is the first-choice medication for the treatment of ADHD in children and adolescents. Over the past two decades, several randomised controlled trials re-peatedly showed its efficacy on both the core symptoms and the quality of life be...

RI Focus
Profilo epidemiologico delle ADR in pediatria

A. Clavenna, M. Bonati

2009/8 — pag. 501-507

A meta-analysis of 8 prospective studies performed in the United States and Europe in the 2001-2007 period estimated that the incidence of ADRs in hospitalised children is 10.9% and in paediatric outpatients 1.0%. The contribution of ADRs to the ho...

RI Focus
L’importanza dei case report in farmacovigilanza

M. Venegoni

2009/8 — pag. 501-507

The publication of case reports is one of the useful didactic instrument to disseminate the knowledge on many or very rare adverse reactions that physicians must know whenever they make prescriptions. Moreover, the activity of pharmacovigilance and...

RI Editoriali
Accesso libero
Reazioni avverse ai farmaci:vigilanza attiva e “ragionevole vigilanza”

F. Marchetti

2009/8 — pag. 483-485

RI Editoriali
Accesso libero
Il Registro dell’ADHD: lo stato dell’arte

M. Bonati, P. Panei

2009/5 — pag. 277